Where Will Planet Labs’ Stock Go Next?
On 4 June 2025 Planet reported Q1 FY 2026 revenue of $66.3 million, up 10% year over…
Sell
48
CCM Quote, Financials, Valuation and Earnings
Last price:
$7.14
Seasonality move
:
1.54%
Day range:
$6.78 - $6.95
52-week range:
$3.80 - $12.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.57x
P/B ratio:
--
Volume:
8K
Avg. volume:
40.7K
1-year change:
-3.5%
Market cap:
$30.2M
Revenue:
$53.5M
EPS (TTM):
-$12.05
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Concord Medical Services Holdings has 72.64% upside to fair value with a price target of -- per share.
CCM vs. S&P 500
-
Over the past 5 trading days, Concord Medical Services Holdings has underperformed the S&P 500 by -5.05% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Concord Medical Services Holdings does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Concord Medical Services Holdings revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Concord Medical Services Holdings reported revenues of --.
Earnings Growth
-
Concord Medical Services Holdings earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Concord Medical Services Holdings reported earnings per share of --.
Enterprise value:
1B
EV / Invested capital:
--
Price / LTM sales:
0.57x
EV / EBIT:
--
EV / Revenue:
19.28x
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$11.2M
Return On Assets:
-6.07%
Net Income Margin (TTM):
-80.33%
Return On Equity:
-19.78%
Return On Invested Capital:
-7.49%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2014-06-30 | 2015-06-30 | 2016-06-30 | 2015-06-30 | 2016-06-30 | |
| Income Statement | ||||||
| Revenue | $66.2M | $101.6M | $84.9M | $28.1M | $19.8M | |
| Gross Profit | -- | -- | -- | $12.8M | $8.6M | |
| Operating Income | -- | -- | -- | $3.2M | -$89.4K | |
| EBITDA | -- | -- | -- | $10.1M | $1.8M | |
| Diluted EPS | -- | -- | -- | $1.31 | -$0.64 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $103.5M | $91.7M | $110.1M | $87.1M | $134.8M | |
| Total Assets | $816.5M | $977.4M | $870.4M | $854M | $921.4M | |
| Current Liabilities | $78.4M | $126.2M | $162.5M | $275.3M | $291.1M | |
| Total Liabilities | $449M | $546.9M | $578.2M | $607.6M | $699.8M | |
| Total Equity | $367.5M | $430.4M | $292.2M | $246.5M | $221.6M | |
| Total Debt | $324M | $391.9M | $435.4M | $431.1M | $513.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-12 | 2024-06-12 | 2024-06-12 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
CCM
Sector
Market Cap
$30.2M
$34.2M
Price % of 52-Week High
54.73%
47.37%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-3.5%
-35.99%
Beta (5-Year)
-0.835
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$7.20
200-day SMA
Buy
Level
$5.68
Bollinger Bands (100)
Buy
Level
4.03 - 6.91
Chaikin Money Flow
Sell
Level
-1.8M
20-day SMA
Sell
Level
$7.60
Relative Strength Index (RSI14)
Sell
Level
47.66
ADX Line
Buy
Level
25.23
Williams %R
Buy
Level
-85.8854
50-day SMA
Buy
Level
$6.30
MACD (12, 26)
Buy
Level
0.12
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
2.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.2734)
Sell
CA Score
(Annual)
Level (-4.6569)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (2.9679)
Buy
Piotroski F Score
(Annual)
Level (4)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
Stock Forecast FAQ
In the current month, CCM has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CCM average analyst price target in the past 3 months is --.
-
Where Will Concord Medical Services Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Concord Medical Services Holdings share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Concord Medical Services Holdings?
Analysts are divided on their view about Concord Medical Services Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Concord Medical Services Holdings is a Sell and believe this share price will drop from its current level to --.
-
What Is Concord Medical Services Holdings's Price Target?
The price target for Concord Medical Services Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CCM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Concord Medical Services Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CCM?
You can purchase shares of Concord Medical Services Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Concord Medical Services Holdings shares.
-
What Is The Concord Medical Services Holdings Share Price Today?
Concord Medical Services Holdings was last trading at $7.14 per share. This represents the most recent stock quote for Concord Medical Services Holdings. Yesterday, Concord Medical Services Holdings closed at $6.95 per share.
-
How To Buy Concord Medical Services Holdings Stock Online?
In order to purchase Concord Medical Services Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will VICI Properties Be in 5 Years?
VICI Properties (NYSE:VICI) is a real estate investment trust focused…
Where Will Exxon Stock Be in 5 Years?
For sure Exxon Mobil (NYSE: XOM) is no hyped-up AI…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
75
INSM alert for Jun 11
Insmed [INSM] is up 7.75% over the past day.
Sell
25
AAON alert for Jun 11
AAON [AAON] is down 3.49% over the past day.
Buy
58
EXOD alert for Jun 11
Exodus Movement [EXOD] is down 8.21% over the past day.
